Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 1.74% vs 5.01% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -125.40% vs -26.74% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -26.71% vs 17.73% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 20.51% vs 0.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Pacira Biosciences, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 7.22% vs -9.82% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 1.74% vs 5.01% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -200.00% vs -70.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -125.40% vs -26.74% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 51.45% vs -52.56% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -26.71% vs 17.73% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 2.17% vs -2.13% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 20.51% vs 0.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






